Main study measure wording changed
Text changed; whether the study measures changed has not been verified. Saved text may be shortened.
Before: Measure: Number of Participants With Adverse Events Time frame: Baseline up to end of study (up to approximately 8 years) Measure: Number of Participants With Laboratory Parameters Abnormalities Description: Laboratory parameters include hematological, serum biochemistry, adrenal laboratories, and urine data. Time frame: Baseline up to end of study (up to approximately 8 years) Measure: Number of Participants With Abnormal Physical Findings Description: Physical findings include weight, physical examination data, systolic and diastolic blood pressure, radial pulse rate, and body temperature. Time frame: Baseline up to end of study (up to approximately 8 years). After: Measure: Number of Participants With Treatment-emergent Adverse Events (TEAEs) Description: An adverse event (AE) was any untoward medical occurrence in a participant who received study drug without regard to possibility of causal relationship. A TEAE was defined as an AE that occurred or worsened on or after the first dose of ataluren and up to 4 weeks after the last dose of ataluren. A summary of other non-serious AEs and all SAEs, regardless of causality is located in the 'Reported AE section'. Time frame: Baseline up to end of study (up to approximately 15 years).
Participant count type changed
Before: Estimated. After: Actual.
Enrollment · participant count changed
Before: 270 participants (planned). After: 265 participants (actual).
Recruitment status changed
Before: Completed. After: Terminated.